These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23722930)

  • 21. Informatics for Metabolomics.
    Kusonmano K; Vongsangnak W; Chumnanpuen P
    Adv Exp Med Biol; 2016; 939():91-115. PubMed ID: 27807745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey.
    Moreno-Torres M; García-Llorens G; Moro E; Méndez R; Quintás G; Castell JV
    Sci Rep; 2021 Nov; 11(1):22119. PubMed ID: 34764412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass Spectrometry-Based Zebrafish Toxicometabolomics: A Review of Analytical and Data Quality Challenges.
    da Silva KM; Iturrospe E; Bars C; Knapen D; Van Cruchten S; Covaci A; van Nuijs ALN
    Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity.
    Guleria A; Kumar A; Kumar U; Raj R; Kumar D
    Curr Top Med Chem; 2018; 18(20):1827-1849. PubMed ID: 30465509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathway Activity Profiling (PAPi): from the metabolite profile to the metabolic pathway activity.
    Aggio RB; Ruggiero K; Villas-Bôas SG
    Bioinformatics; 2010 Dec; 26(23):2969-76. PubMed ID: 20929912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling short time series in metabolomics: a functional data analysis approach.
    Montana G; Berk M; Ebbels T
    Adv Exp Med Biol; 2011; 696():307-15. PubMed ID: 21431571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FutureTox II: in vitro data and in silico models for predictive toxicology.
    Knudsen TB; Keller DA; Sander M; Carney EW; Doerrer NG; Eaton DL; Fitzpatrick SC; Hastings KL; Mendrick DL; Tice RR; Watkins PB; Whelan M
    Toxicol Sci; 2015 Feb; 143(2):256-67. PubMed ID: 25628403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the human toxome by systems toxicology.
    Bouhifd M; Hogberg HT; Kleensang A; Maertens A; Zhao L; Hartung T
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):24-31. PubMed ID: 24443875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics in toxicology: preclinical and clinical applications.
    Robertson DG; Watkins PB; Reily MD
    Toxicol Sci; 2011 Mar; 120 Suppl 1():S146-70. PubMed ID: 21127352
    [No Abstract]   [Full Text] [Related]  

  • 34. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha.
    Montanez JE; Peters JM; Correll JB; Gonzalez FJ; Patterson AD
    Toxicol Pathol; 2013 Feb; 41(2):410-8. PubMed ID: 23197196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of metabolomics in nanotoxicity].
    Zou XX; Wang HJ; Liu LH; Zhang B
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Sep; 38(9):712-717. PubMed ID: 33036542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network Marker Selection for Untargeted LC-MS Metabolomics Data.
    Cai Q; Alvarez JA; Kang J; Yu T
    J Proteome Res; 2017 Mar; 16(3):1261-1269. PubMed ID: 28168878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of Metabolomics in Forensic Toxicology and Forensic Medicine.
    Szeremeta M; Pietrowska K; Niemcunowicz-Janica A; Kretowski A; Ciborowski M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of Experimental Methods and Study Design in Metabolomics, and Statistical and Pathway Considerations.
    Barnes S
    Methods Mol Biol; 2020; 2104():1-10. PubMed ID: 31953809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicometabolomics as a tool for next generation environmental risk assessment.
    Bernhard A; Poulsen R; Brun Hansen AM; Hansen M
    EFSA J; 2023 Nov; 21(Suppl 1):e211005. PubMed ID: 38047121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.